{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:50:10Z","timestamp":1777693810315,"version":"3.51.4"},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1097\/gco.0000000000000099","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T12:03:54Z","timestamp":1408622634000},"page":"332-338","source":"Crossref","is-referenced-by-count":32,"title":["Precocious puberty"],"prefix":"10.1097","volume":"26","author":[{"given":"E. Kirk","family":"Neely","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie S.","family":"Crossen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210129","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1210\/jc.2013-1024","article-title":"Treatment and outcomes of precocious puberty: an update.","volume":"98","author":"Fuqua","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R2-3-20210129","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2014.40","article-title":"Pros and cons of GnRHa treatment for early puberty in girls.","volume":"10","author":"Willemsen","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"R3-3-20210129","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000336325","article-title":"Recent secular trends in pubertal timing: implications for evaluation and diagnosis of precocious puberty.","volume":"77","author":"Sorensen","year":"2012","journal-title":"Horm Res Paediatr"},{"key":"R4-3-20210129","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa1111184","article-title":"Inactivating KiSS1 mutation and hypogonadotropic hypogonadism.","volume":"366","author":"Topaloglu","year":"2012","journal-title":"N Engl J Med"},{"key":"R5-3-20210129","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1210\/jc.2009-2600","article-title":"TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans.","volume":"95","author":"Young","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-3-20210129","doi-asserted-by":"crossref","first-page":"10972","DOI":"10.1073\/pnas.1834399100","article-title":"Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54.","volume":"100","author":"De Roux","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R7-3-20210129","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000083140","article-title":"Kisspeptin activation of gonadotropin releasing hormone neurons and regulation of KiSS-1 mRNA in the male rat.","volume":"80","author":"Irwig","year":"2004","journal-title":"Neuroendocrinology"},{"key":"R8-3-20210129","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1073\/pnas.0409330102","article-title":"Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54.","volume":"102","author":"Messager","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"R9-3-20210129","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1073\/pnas.0409822102","article-title":"Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primates.","volume":"102","author":"Shahab","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"R10-3-20210129","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1210\/en.2005-0323","article-title":"Differential regulation of KiSS-1 mRNA expression by sex steroids in the brain of the male mouse.","volume":"146","author":"Smith","year":"2005","journal-title":"Endocrinology"},{"key":"R11-3-20210129","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ng.306","article-title":"TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction.","volume":"4","author":"Topaloglu","year":"2009","journal-title":"Nat Genet"},{"key":"R12-3-20210129","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000336376","article-title":"Kisspeptin restores pulsatile LH secretion in patients with neurokinin B signaling deficiencies: physiological, pathophysiological and therapeutic implications.","volume":"97","author":"Young","year":"2013","journal-title":"Neuroendocrinology"},{"key":"R13-3-20210129","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrendo.2013.120","article-title":"Current and future applications of GnRH, kisspeptin and neurokinin B analogues.","volume":"9","author":"Millar","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"R14-3-20210129","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1542\/peds.99.4.505","article-title":"Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network.","volume":"99","author":"Herman-Giddens","year":"1997","journal-title":"Pediatrics"},{"key":"R15-3-20210129","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1542\/peds.2012-3773","article-title":"Onset of breast development in a longitudinal cohort.","volume":"132","author":"Biro","year":"2013","journal-title":"Pediatrics"},{"issue":"Suppl 3","key":"R16-3-20210129","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1542\/peds.2007-1813D","article-title":"Examination of US puberty-timing data from 1940 to 1994 for secular trends: panel findings.","volume":"121","author":"Euling","year":"2008","journal-title":"Pediatrics"},{"key":"R17-3-20210129","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1542\/peds.104.4.936","article-title":"Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society.","volume":"104","author":"Kaplowitz","year":"1999","journal-title":"Pediatrics"},{"key":"R18-3-20210129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jadohealth.2006.10.002","article-title":"Has age at menarche changed Results from the National Health and Nutrition Examination Survey (NHANES) 1999-2004.","volume":"40","author":"McDowell","year":"2007","journal-title":"J Adolesc Health"},{"key":"R19-3-20210129","first-page":"47","article-title":"Are pubertal changes in girls before age 8 benign P","volume":"111","author":"Midyett","year":"2003","journal-title":"ediatrics"},{"key":"R20-3-20210129","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1210\/jc.2010-2745","article-title":"Diagnostic work-up of 449 consecutive girls who were referred to be evaluated for precocious puberty.","volume":"96","author":"Mogensen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-3-20210129","doi-asserted-by":"crossref","first-page":"e29829","DOI":"10.1371\/journal.pone.0029829","article-title":"Pathological and incidental findings on brain MRI in a single-center study of 229 consecutive girls with early or precocious puberty.","volume":"7","author":"Mogensen","year":"2012","journal-title":"PLoS One"},{"key":"R22-3-20210129","doi-asserted-by":"crossref","first-page":"e932","DOI":"10.1542\/peds.2008-2491","article-title":"Recent decline in age at breast development: the Copenhagen Puberty Study.","volume":"123","author":"Aksglaede","year":"2009","journal-title":"Pediatrics"},{"key":"R23-3-20210129","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/archpediatrics.2009.261","article-title":"Eunice Kennedy Shriver NICHD Early Child Care Research NetworkLongitudinal development of secondary sexual characteristics in girls and boys between ages 9 12 and 15 12 years.","volume":"164","author":"Susman","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R24-3-20210129","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1542\/peds.2007-1813C","article-title":"Role of environmental factors in the timing of puberty.","volume":"121","author":"Euling","year":"2008","journal-title":"Pediatrics"},{"key":"R25-3-20210129","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11154-008-9096-y","article-title":"Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism.","volume":"10","author":"Ibanez","year":"2009","journal-title":"Rev Endocr Metab Disord"},{"key":"R26-3-20210129","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.fertnstert.2010.08.052","article-title":"Early metformin therapy to delay menarche and augment height in girls with precocious pubarche.","volume":"95","author":"Ibanez","year":"2011","journal-title":"Fertil Steril"},{"key":"R27-3-20210129","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/archdischild-2011-300011","article-title":"Premature adrenarche.","volume":"97","author":"Williams","year":"2012","journal-title":"Arch Dis Child"},{"key":"R28-3-20210129","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12519-013-0411-7","article-title":"Sexual precocity and its treatment.","volume":"9","author":"Brown","year":"2013","journal-title":"World J Pediatr"},{"key":"R29-3-20210129","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1210\/jcem-67-3-474","article-title":"Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone.","volume":"67","author":"Pescovitz","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-3-20210129","first-page":"30","article-title":"Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin-releasing hormone test.","volume":"78","author":"Ibanez","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"R31-3-20210129","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jpeds.2009.09.071","article-title":"Premature thelarche: age at presentation affects clinical course but not clinical characteristics or risk to progress to precocious puberty.","volume":"156","author":"De Vries","year":"2010","journal-title":"J Pediatr"},{"key":"R32-3-20210129","first-page":"412","article-title":"The spectrum of McCune Albright syndrome.","volume":"4","author":"Zacharin","year":"2007","journal-title":"Pediatr Endocrinol Rev"},{"key":"R33-3-20210129","first-page":"64","article-title":"Peripheral precocious puberty: causes and current management.","volume":"71","author":"Eugster","year":"2009","journal-title":"Horm Res"},{"key":"R34-3-20210129","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2006-2350","article-title":"Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study.","volume":"92","author":"Feuillan","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-3-20210129","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/ng.714","article-title":"Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies.","volume":"42","author":"Elks","year":"2010","journal-title":"Nat Genet"},{"key":"R36-3-20210129","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1210\/jc.2010-1025","article-title":"Central precocious puberty in children living in Spain: incidence, prevalence, and influence of adoption and immigration.","volume":"95","author":"Soriano-Guillen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-3-20210129","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0022-3476(95)70254-7","article-title":"Normal ranges for immunochemiluminometric gonadotropin assays.","volume":"127","author":"Neely","year":"1995","journal-title":"J Pediatr"},{"key":"R38-3-20210129","first-page":"599","article-title":"Laboratory testing of gonadal steroids in children.","volume":"5","author":"Albrecht","year":"2007","journal-title":"Pediatr Endocrinol Rev"},{"key":"R39-3-20210129","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1210\/jc.2006-1569","article-title":"Assessment of basal and gonadotropin-releasing hormone-stimulated gonadotropins by immunochemiluminometric and immunofluorometric assays in normal children.","volume":"92","author":"Resende","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R40-3-20210129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(95)70255-5","article-title":"Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty.","volume":"127","author":"Neely","year":"1995","journal-title":"J Pediatr"},{"key":"R41-3-20210129","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1210\/jc.2008-1655","article-title":"Blunted sleep-related luteinizing hormone rise in healthy premenarcheal pubertal girls with elevated body mass index.","volume":"94","author":"Bordini","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R42-3-20210129","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2265.2010.03796.x","article-title":"Leuprolide stimulation testing for the evaluation of early female sexual maturation.","volume":"73","author":"Sathasivam","year":"2010","journal-title":"Clin Endocrinol"},{"key":"R43-3-20210129","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jpeds.2012.06.015","article-title":"Pharmacodynamics of aqueous leuprolide acetate stimulation testing in girls: correlation between clinical diagnosis and time of peak luteinizing hormone level.","volume":"61","author":"Chi","year":"2012","journal-title":"J Pediatr"},{"key":"R44-3-20210129","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jpeds.2011.02.032","article-title":"Pelvic ultrasonography in the evaluation of central precocious puberty: comparison with leuprolide stimulation test.","volume":"159","author":"Sathasivam","year":"2011","journal-title":"J Pediatr"},{"key":"R45-3-20210129","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/uog.154","article-title":"Pelvic ultrasound and color Doppler findings in different isosexual precocities.","volume":"22","author":"Battaglia","year":"2003","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R46-3-20210129","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1542\/peds.2008-1783","article-title":"Consensus statement on the use of gonadotropin-releasing hormone analogs in children.","volume":"123","author":"Carel","year":"2009","journal-title":"Pediatrics"},{"key":"R47-3-20210129","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1517\/14656566.2013.806489","article-title":"Current pharmacotherapy of central precocious puberty by GnRH analogs: certainties and uncertainties.","volume":"14","author":"Bertelloni","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"R48-3-20210129","doi-asserted-by":"crossref","first-page":"398639","DOI":"10.1186\/1687-9856-2010-398639","article-title":"Leuprolide acetate 1-month depot for central precocious puberty: hormonal suppression and recovery.","volume":"2010","author":"Neely","year":"2010","journal-title":"Int J Pediatr Endocrinol"},{"key":"R49-3-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1687-9856-2011-7","article-title":"Efficacy of leuprolide acetate 1-month depot for central precocious puberty (CPP): growth outcomes during a prospective, longitudinal study.","volume":"2011","author":"Lee","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"key":"R50-3-20210129","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1210\/jc.2005-1500","article-title":"Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty.","volume":"91","author":"Badaru","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R51-3-20210129","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jpeds.2011.05.036","article-title":"A randomized trial of 1- and 3-month depot leuprolide doses in the treatment of central precocious puberty.","volume":"159","author":"Fuld","year":"2011","journal-title":"J Pediatr"},{"key":"R52-3-20210129","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1210\/jc.2011-2704","article-title":"Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty.","volume":"97","author":"Lee","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R53-3-20210129","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1210\/jc.2006-2479","article-title":"Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: a multicenter trial.","volume":"92","author":"Eugster","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R54-3-20210129","doi-asserted-by":"crossref","first-page":"812517","DOI":"10.1186\/1687-9856-2009-812517","article-title":"Results of a second year of therapy with the 12-month histrelin implant for the treatment of central precocious puberty.","volume":"2009","author":"Rahhal","year":"2009","journal-title":"Int J Pediatr Endocrinol"},{"key":"R55-3-20210129","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jpeds.2013.05.033","article-title":"A single histrelin implant is effective for 2 years for treatment of central precocious puberty.","volume":"163","author":"Lewis","year":"2013","journal-title":"J Pediatr"},{"key":"R56-3-20210129","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1542\/peds.109.2.e30","article-title":"Serum luteinizing hormone rises within minutes after depot leuprolide injection: implications for monitoring therapy.","volume":"109","author":"Bhatia","year":"2002","journal-title":"Pediatrics"},{"key":"R57-3-20210129","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1210\/jc.2003-031537","article-title":"A single luteinizing hormone determination 2h after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls.","volume":"89","author":"Brito","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R58-3-20210129","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jpeds.2012.08.038","article-title":"Random luteinizing hormone often remains pubertal in children treated with the histrelin implant for central precocious puberty.","volume":"162","author":"Lewis","year":"2013","journal-title":"J Pediatr"},{"key":"R59-3-20210129","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1687-9856-2013-20","article-title":"Random unstimulated pediatric luteinizing hormone levels are not reliable in the assessment of pubertal suppression during histrelin implant therapy.","volume":"2013","author":"Neely","year":"2013","journal-title":"Int J Pediatr Endocrinol"},{"key":"R60-3-20210129","first-page":"306","article-title":"Review of outcomes after cessation of gonadotropin-releasing hormone agonist treatment of girls with precocious puberty.","volume":"11","author":"Thornton","year":"2014","journal-title":"Pediatr Endocrinol Rev"},{"key":"R61-3-20210129","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1210\/jcem.86.10.7915","article-title":"Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience.","volume":"86","author":"Klein","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R62-3-20210129","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1210\/jc.2007-1216","article-title":"Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.","volume":"93","author":"Pasquino","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R63-3-20210129","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1210\/jc.2007-0321","article-title":"Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity.","volume":"92","author":"Lazar","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R64-3-20210129","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/adc.81.4.329","article-title":"Randomised trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5-8.5 years.","volume":"81","author":"Cassio","year":"1999","journal-title":"Arch Dis Child"},{"key":"R65-3-20210129","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/1471-2458-9-446","article-title":"Early pubertal onset and its relationship with sexual risk taking, substance use and antisocial behaviour: a preliminary cross-sectional study.","volume":"9","author":"Downing","year":"2009","journal-title":"BMC Public Health"},{"key":"R66-3-20210129","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1037\/a0024008","article-title":"Elevated social anxiety among early maturing girls.","volume":"47","author":"Blumenthal","year":"2011","journal-title":"Dev Psychol"},{"key":"R67-3-20210129","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1687-9856-2014-5","article-title":"Higher prevalence of obesity and overweight without an adverse metabolic profile in girls with central precocious puberty compared to girls with early puberty, regardless of GnRH analogue treatment.","volume":"2014","author":"Colmenares","year":"2014","journal-title":"Intl J Pediatr Endocrinol"},{"key":"R68-3-20210129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00431-006-0207-z","article-title":"Menstrual cycle pattern during the first gynaecological years in girls with precocious puberty following gonadotropin-releasing hormone analogue treatment.","volume":"166","author":"Arrigo","year":"2007","journal-title":"Eur J Pediatr"},{"key":"R69-3-20210129","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2265.2004.02146.x","article-title":"Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.","volume":"61","author":"Paterson","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R70-3-20210129","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3109\/09513590.2010.507289","article-title":"Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.","volume":"27","author":"Poomthavorn","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"R71-3-20210129","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jpeds.2013.01.021","article-title":"Time to menarche and final height after histrelin implant treatment for central precocious puberty.","volume":"163","author":"Gillis","year":"2013","journal-title":"J Pediatr"},{"key":"R72-3-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.mce.2006.04.012","article-title":"Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function.","volume":"254-","author":"Heger","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"R73-3-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/EJE-09-1102","article-title":"GNRH analog therapy in girls with early puberty is associated with the achievement of predicted final height but also with increased risk of polycystic ovary syndrome.","volume":"163","author":"Chiavaroli","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"R74-3-20210129","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.fertnstert.2008.11.016","article-title":"Prevalence of polycystic ovary syndrome in young women who had idiopathic central precocious puberty.","volume":"93","author":"Franceschi","year":"2010","journal-title":"Fertil Steril"},{"key":"R75-3-20210129","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1210\/jc.2009-0793","article-title":"The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study.","volume":"95","author":"Magiakou","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R76-3-20210129","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jpeds.2006.05.026","article-title":"Reproductive outcome in patients treated and not treated for idiopathic early puberty: long-term results of a randomized trial in adults.","volume":"149","author":"Cassio","year":"2006","journal-title":"J Pediatr"}],"container-title":["Current Opinion in Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GCO.0000000000000099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:42:11Z","timestamp":1620952931000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001703-201410000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/gco.0000000000000099","relation":{},"ISSN":["1040-872X"],"issn-type":[{"value":"1040-872X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}